Used as a selective inhibitor of p38 MAP kinase, this compound is primarily employed in research settings to study inflammatory pathways and cellular responses involved in immune regulation. It helps in investigating the role of p38 signaling in diseases such as arthritis, chronic obstructive pulmonary disease (COPD), and other conditions involving inflammation. Due to its high selectivity, it is valuable in preclinical studies for assessing potential therapeutic targets and evaluating the effects of p38 inhibition on cytokine production and cell proliferation.